Table 7 Antifungal Susceptibility Profile of Candida spp. Isolated from Surgical Wound Patients
Candida spp. | Fluconazole | Voriconazole | Itraconazole | |||
|---|---|---|---|---|---|---|
| Â | S | R | S | R | S | R |
C. albicans (n = 54) | 48 (88.88%) | 6 (11.11%) | 54 (100%) | 0 (0%) | 53 (98.14) | 1 (1.85%) |
C. glabrata (n = 32) | 26 (81.25%) | 6 (18.75%) | 29 (90.62%) | 3 (9.37%) | 28 (87.5) | 4 (12.5%) |
C. tropicalis (n = 12) | 11 (91.66%) | 1 (8.33%) | 11 (91.66%) | 1 (8.33%) | 10 (83.33%) | 2 (16.66%) |
C. krusei (n = 13) | 0 (0%) | 13 (100%) | 12 (92.30%) | 1 (7.69%) | 13 (100%) | 0 (0%) |
C. parapsilosis (n = 17) | 17 (100%) | 0 (0%) | 17 (100%) | 0 (0%) | 17 (100) | 0 (0%) |